Scientist- Senior Scientist
Surrozen
Summary
We are seeking a highly motivated Scientist, full-time position to support drug development programs in the ophthalmology space. The Scientist will be involved in conducting cell-based assays for evaluating antibody drug efficacy. The Scientist will also be involved in establishing and optimizing advanced in vitro model systems, leveraging state-of-the-art technologies and techniques, to help understand drug MOA.
Job description
This position offers an exciting opportunity to contribute to many of Surrozen's preclinical and clinical programs to potentially transform the treatment options of severe eye diseases, including DME, nAMD and dAMD.
Key Responsibilities
- Develop and optimize high-throughput screening assays to test and rank large pools of drug candidates; participate in lead-optimization.
- Establish cell or tissue-based assays to explore disease mechanisms, Wnt biology, ocular biology and test new molecules targeting different mechanisms.
- Identify potential new targets for drug intervention and validate their role in the disease process through advanced molecular and cell biology techniques.
- Systematically analyze complex experimental data, critically evaluate and interpret data, draw conclusions, and present findings to project teams to guide drug development decisions.
- Work closely with cross-functional teams, including protein biochemists, pharmacologists, and data scientists, to drive discovery programs.
- Engage with and oversee work conducted by contract research organizations (CROs) for specialized tasks, and coordinate projects with research partners.
- Develop and maintain communication with a network of scientific advisors and consultants.
- Stay current with scientific literature and contribute to setting the strategic direction for discovery efforts in the ophthalmology therapeutics field.
- Publish data and research discoveries as conference abstracts, patents and peer-reviewed papers as guided by Surrozen publication strategy.
Requirements
- Ph.D. in Biochemistry, Cell Biology, Molecular Biology, Developmental Biology, Neurobiology or related fields
- Strong track record of peer-reviewed publications
- Minimum 5 years hands-on experience in Wnt biology and/or retinal biology and/or vasculature biology research
- Demonstrated strong wet-lab molecular and cell biology techniques (molecular cloning, qPCR, siRNA, CRISPR-Cas9 gene editing, IF/IHC, ISH/FISH, FACS, ELISA, Western blotting, protein IP, mammalian cell/organoid culture, reporter/enzymatic/FRET cell-based assays, animal tissue manipulation, dissociation and primary cell isolation, tissue explant cultures)
- Experience with fluorescence confocal microscopy and imaging analysis
- Familiarity with state-of-the-art in vitro, ex vivo and animal retinal disease models
- Experience and good knowledge in advancing antibody therapeutics
- Recent experience with high-throughput sequencing, single-cell sequencing, spatial transcriptomics, proteomic workflow, R programming and data analysis
- Experience in integrating AI agents into scientific discovery and drug development workflow
- Proficiency with MS Office, SharePoint, GraphPad Prism and electronic notebook software and cloud tools
- Excellent organizational and communication skills
- Attention to detail, data oriented, problem solving, self-motivated
- Experience in coaching junior scientists and research staff
- Strong interpersonal skills and a team player
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- IRA
- Life Insurance
- Paid Time Off
- Family Leave
- Short & Long Term Disability
- Training & Development
- Free Food & Snacks
- Wellness Resources
- Stock Option Plan
Company overview
Surrozen is a biotechnology company pioneering the development of novel therapeutics that selectively activate the Wnt signaling pathway for tissue repair and regeneration. The company's proprietary platform technology, called SWAP (Surrozen Wnt-Activating Platform), enables the creation of targeted biologics that can precisely modulate Wnt signaling in specific tissues and cell types. This approach addresses one of the major challenges in regenerative medicine - achieving controlled activation of Wnt signaling without the safety concerns associated with broad pathway activation. Surrozen's pipeline focuses on developing treatments for serious diseases in multiple therapeutic areas, including gastrointestinal, ocular, and neurological disorders. The company's innovative technology represents a significant advancement in the field of regenerative medicine, offering the potential to restore tissue function and treat degenerative conditions through precise biological engineering. Surrozen's research aims to unlock the therapeutic potential of Wnt signaling, a fundamental pathway in development and tissue homeostasis, to create transformative medicines for patients with unmet medical needs.